Introduction {#s1}
============

Mitochondria provide aerobic eukaryotes with adenosine triphosphate (ATP), which involves carbohydrates and fatty acid oxidation ([@bib61]), as well as numerous other vital functions like lipid and sterol synthesis ([@bib28]) and formation of iron-sulfur cluster ([@bib46]). Mitochondria possess their own genome, remnant of an ancestral prokaryotic genome ([@bib24]; [@bib48]) that has been considerably reduced in size due to a massive transfer of genes during eukaryotic evolution ([@bib67]). As a result, most of the proteins required for mitochondrial structure and functions are expressed from the nuclear genome (\>99%) and synthetized as precursors targeted to the mitochondria by mitochondrial targeting signals (MTS), that in some case are cleaved upon import ([@bib11]). In the yeast *S. cerevisiae*, about a third of the mitochondrial proteins (mitoproteome) have been suggested to be dual localized ([@bib5]; [@bib17]; [@bib36]), and have been named echoforms (or echoproteins) to accentuate the fact that two identical or nearly identical forms of a protein, can reside in the mitochondria and another compartment ([@bib6]). Due to these two coexisting forms and the difficulty to obtain pure mitochondria, determination of a complete mitoproteome remains challenging and gave rise to conflicting results ([@bib43]; [@bib49]; [@bib55]; [@bib63]).

Among all possible methods used to identify the subcellular destination of a protein, engineering green fluorescent protein (GFP) fusions has the major advantage that these fusions can be visualized in living cells using epifluorescence microscopy. This method is suitable to discriminate the cytosolic and mitochondrial pools of dual localized proteins when the cytosolic fraction has a lower concentration than the mitochondrial one ([@bib72]). However, when the cytosolic echoform is more abundant than the mitochondrial one, this will inevitably eclipse the mitochondrial fluorescence signal. To bypass this drawback, we designed a yeast strain containing a new type of Split-GFP system termed Bi-Genomic Mitochondrial-Split-GFP (BiG Mito-Split-GFP) because one moiety of the GFP is encoded by the mitochondrial genome, while the other one is fused to the nuclear-encoded protein to be tested. By doing so, both Split-GFP fragments are translated in separate compartments and only mitochondrial proteins or echoforms of dual localized proteins trigger GFP reconstitution and can be visualized by fluorescence microscopy of living cells.

We herein first validated this system with proteins exclusively localized in the mitochondria and with the dual localized glutamyl-tRNA synthetase (cERS) that resides and functions in both the cytosol and mitochondria as we have shown previously ([@bib20]; [@bib21]). We next applied our Split-GFP strategy to the near-complete set of all known yeast cytosolic aminoacyl-tRNA synthetases. Interestingly, we discovered that two of them, cytosolic phenylalanyl-tRNA synthetase 2 (cFRS2) and cytosolic histidinyl-tRNA synthetase have a dual localization. We also confirmed the recently reported dual cellular location of cytosolic cysteinyl-tRNA synthetase (cCRS) ([@bib51]). We further demonstrate that our yeast BiG Mito-Split-GFP strain can be used to better define non-conventional mitochondrial targeting sequences and to probe the mitochondrial importability of proteins from other eukaryotic species (human, mouse and plants). For instance, we show that the mammalian Argonaute 2 protein heterologously expressed in yeast localizes inside mitochondria.

Results {#s2}
=======

Construction of the BiG Mito-Split-GFP strain encoding the GFP~β1-10~ fragment in the mitochondrial genome {#s2-1}
----------------------------------------------------------------------------------------------------------

We used the scaffold of the self-assembling Superfolder Split-GFP fragments designed by Cabantous and coworkers ([@bib9]; [@bib52]), where the 11 beta strands forming active Superfolder GFP are separated in a fragment encompassing the 10 first beta strands (GFP~β1-10~) and a smaller one consisting of the remaining beta strand (GFP~β11~). Seven amino acid (aa) residues of GFP~β1-10~ and three of GFP~β11~ were replaced in order to increase the stability and the self-assembly of both fragments ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). To increase the fluorescent signal and facilitate observation of low-abundant proteins, we concatenated and fused three β11 strands (GFP~β11-chaplet;\ β11ch~) linked by GTGGGSGGGSTS spacers (see Materials and methods for DNA sequence, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}, as in [@bib33]; [Figure 1A](#fig1){ref-type="fig"}).

![Engineering of the BiG Mito-Split-GFP system in *S. cerevisiae.*\
(**A**) Principle of the Split-GFP system. When present in the same subcellular compartment, two fragments of GFP namely GFP~β1-10~ and GFP~β11ch~ can auto-assemble to form a fluorescent BiG Mito-Split-GFP chaplet (three reconstituted GFPs). *GFP~β1-10~* sequence encoding the first ten beta strands of GFP has been integrated into the mitochondrial genome under the control of the *ATP6* promoter. GFP~β11ch~ consists of a tandemly fused form of the eleventh beta strand of GFP and is expressed from a plasmid under the control of a strong GPD promoter (pGPD). The molecular weight of the tag is indicated. (**B**) Growth assay on permissive SC Glu plates, respiratory plates (SC Gly), and restrictive media lacking arginine (SC Glu -Arg) of the different strains used in the study (N = 2). All generated strains are derivative from MR6. (**C**) ATP synthesis rates of the MR6 and RKY112 strains presented as the percent of the wild type control strain (N = 2). P-value was 0.7456 (not significant). 95% confidence interval was −273.4 to 229.9, R squared = 0.064 (**D**) Mitochondrial translation products in the MR6 and RKY112 strains (N = 2). Cells were grown in rich galactose medium. Pulse-chase of radiolabeled \[^35^S\]methionine + \[^35^S\]cysteine was performed by a 20 min incubation in the presence of cycloheximide. Total cellular extracts were separated by SDS PAGE in two different polyacrylamide gels prepared with a 30:0.8 ratio of acrylamide and bis-acrylamide. Upper gel: 12% polyacrylamide gel containing 4 M urea and 25% glycerol. Lower gel: 17.5% polyacrylamide gel. Gels were dried and exposed to X-ray film. The representative gels are shown.\
Figure 1---source data 1.Respiratory competency and translation of mtDNA-encoded respiratory subunits of the strains used in this study.Growth assay on permissive SC Glu plates, respiratory plates (SC Gly), and restrictive media lacking arginine (SC Glu -Arg) of the different strains used in the study (related to [Figure 1B](#fig1){ref-type="fig"}). Mitochondrial translation products in the MR6 and RKY112 strains (N = 2) monitored by pulse-chase labeling with radiolabeled \[^35^S\]methionine and \[^35^S\]cysteine (related to [Figure 1D](#fig1){ref-type="fig"}).\
Figure 1---source data 2.Statistics of the comparison of ATP synthesis rates between RKY112 and MR6 strains (related to [Figure 1C](#fig1){ref-type="fig"}).](elife-56649-fig1){#fig1}

Our objective was to integrate the gene encoding the GFP~β1-10~ fragment into the mtDNA so that it will only be translated inside the mitochondrial matrix, while the GFP~β11ch~ fragment is fused to the nuclear-encoded protein of interest and thus translated by cytosolic ribosomes ([Figure 1A](#fig1){ref-type="fig"}). To achieve this, we constructed a strain (RKY112) in which the coding sequence of the *ATP6* gene has been replaced by *ARG8m* (*atp6::ARG8m*), and where *ATP6* is integrated at the mitochondrial *COX*2 locus under the control of the 5' and 3' UTRs of *COX2* gene ([Supplementary file 1](#supp1){ref-type="supplementary-material"}; [Table 1](#table1){ref-type="table"}; [Figure 1---figure supplement 2A--C](#fig1s2){ref-type="fig"}; see Materials and methods section for details). The RKY112 strain grew well on respiratory carbon source as wild type yeast (MR6) ([Figure 1B](#fig1){ref-type="fig"}), produced ATP effectively ([Figure 1C](#fig1){ref-type="fig"}), and expressed normally Atp6 and all the other mitochondria-encoded proteins ([Figure 1D](#fig1){ref-type="fig"}). We next integrated at the *atp6::ARG8m* locus of RKY112 strain mtDNA, the sequence encoding GFP~β1-10~ ([Figure 1A](#fig1){ref-type="fig"}; [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). To this end, we first introduced into the ρ^0^ mitochondria (*i.e.* totally lacking mtDNA) of DFS160 strain, a plasmid carrying the *GFP~β1-10~* sequence flanked by 5' and 3' UTR sequences of the native *ATP6* locus (pRK67, see Materials and methods for DNA sequence), yielding the RKY172 strain (bearing a non-functional synthetic ρ^-S^ mtDNA, [Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}). This strain was crossed to RKY112 to enable replacement of *ARG8m* with *GFP~β1-10~*. The desired recombinant clones, called RKY176, were identified by virtue of their incapacity to grow in media lacking arginine due to the loss of *ARG8m* and their capacity to grow in respiratory media ([Figure 1B](#fig1){ref-type="fig"}). Integration of *GFP~β1-10~* in mtDNA was confirmed by PCR ([Figure 1---figure supplement 2E](#fig1s2){ref-type="fig"}, [Supplementary file 2](#supp2){ref-type="supplementary-material"}) and Western blot with anti-GFP antibodies ([Figure 2C](#fig2){ref-type="fig"}). Finally, the BiG Mito-Split-GFP strain ([Table 1](#table1){ref-type="table"}) was obtained by restoring the nuclear *ADE2* locus in order to eliminate interfering fluorescence emission of the vacuole due to accumulation of a pink adenine precursor ([@bib19]; [@bib35]).

![The reconstitution and fluorescence emission of the BiG Mito-Split-GFP is confined to mitochondria and exclusively generated by mitochondrial proteins.\
(**A**) Schematic of the spatial localization of proteins used as positive mitochondrial control proteins (Atp4, Pam16), negative cytosolic control protein (Pgk1) and as dual localized protein (cERS) in *S. cerevisiae*. (**B**) Empty pAG414pGPD~β11ch~ vector (EV) or pAG414pGPD~β11ch~ vectors expressing each of the four GFP~β11ch~-tagged proteins used as markers in our study were transformed into the BiG Mito-Split-GFP strain. cERS~β11ch~ was either expressed under the dependence of the GPD (pGPD) or its own promoter (pGUS1) from a centromeric plasmid. GFP reconstitution upon mitochondrial import was followed by epifluorescence microscopy (N = 3). (**C**) Immunodetection of the GFP~β1-10~, cERS~β11ch~ and Pgk1~β11ch~ fusion protein in whole cell extract from the transformed BiG Mito-Split-GFP strain using anti-GFP and -Pgk1 antibodies, confirming expression of Pgk1~β11ch~. Loading control: stain-free. The representative gels are shown. (**D**) The strains described in the legend of panel (**B**) were used for three-dimensional reconstitution of yeast mitochondrial network (N = 1). Z-Stack images from Pam16~β11ch~, Atp4~β11ch~, cERS~β11ch~ and Pgk1~β11ch~ were taken using an Airyscan microscope. Scale bar: 1 µm. (**E**) Flow cytometry measurements of total GFP fluorescence of the BiG Mito-Split-GFP strain stably expressing Pgk1~β11ch~ or Pam16~β11ch~ (N = 3). (**F**) The mitochondrial GatF protein was fused to the GFP~β1-10~ fragment (mtGatF ~β1-10~), thereby targeting the ten first GFP beta-strands to mitochondria after being transcribed in the nucleus and translated in the cytoplasm. This construct was co-expressed with either cERS~β11ch~ or Pgk1~β11ch~. The GFP reconstitution was monitored by epifluorescence microscopy. Mitochondria were stained with MitoTracker Red CMXRos. Scale bar: 5 µm. Representative fields are shown.\
Figure 2---source data 1.Micrographs of the BiG Mito-Split-GFP expressing Pgk1~β11ch~, cERS~β11ch~, Pam16~β11ch~, (related to [Figure 2B](#fig2){ref-type="fig"}).The micrograph of the BiG Mito-Split-GFP expressing Pgk1~β11ch~ which is magnified in [Figure 2B](#fig2){ref-type="fig"} is presented here with adjusted or enhanced contrast settings. A new panel of the BiG Mito-Split-GFP expressing Pgk1~β11ch~ was added with enhanced or adjusted contrast settings.\
Figure 2---source data 2.Confirmation of the expression of the GFP~β1-10~, cERS~β11ch~ and Pgk1~β11ch~ fusion proteins in whole cell extract from the transformed BiG Mito-Split-GFP strains (Related to [Figure 2C](#fig2){ref-type="fig"}).Antibodies used for immunoblotting are indicated below WBs. Loading control corresponds to the gel stained with the stain-free procedure.\
Figure 2---source data 3.Flow cytometry measurements of total GFP fluorescence of the three biological replicates of the BiG Mito-Split-GFP strain stably expressing Pgk1~β11ch~ or Pam16~β11ch~ (related to [Figure 2F](#fig2){ref-type="fig"}).](elife-56649-fig2){#fig2}

###### Genotypes of yeast strains used or generated for this study.

  Strain                              Nuclear genotype                                                           mtDNA                                                  Source
  ----------------------------------- -------------------------------------------------------------------------- ------------------------------------------------------ ------------
  MR6                                 *MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 arg8::HIS3*          *ρ^+^*                                                 [@bib54]
  DFS160                              *MATα leu2∆ ura3-52 ade2-101 arg8::URA3 kar1-1*                            *ρ^o^*                                                 [@bib65]
  NB40-3C                             *MATa lys2 leu2-3,112 ura3-52 his3∆HindIII arg8::hisG*                     *ρ^+^ cox2-62*                                         [@bib65]
  MR10                                *MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 arg8::hisG*          *ρ^+^ atp6::ARG8m*                                     [@bib54]
  SDC30                               *MATα leu2∆ ura3-52 ade2-101 arg8::URA3 kar1-1*                            *ρ^-^COX2 ATP6*                                        [@bib54]
  YTMT2                               *MATα leu2∆ ura3-52 ade2-101 arg8::URA3 kar1-1*                            *ρ^+^cox2-62*                                          This study
  RKY83                               *MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 arg8::HIS3*               *ρ^+^cox2-62 atp6::ARG8m*                              This study
  RKY89                               *MATα leu2∆ ura3-52 ade2-101 arg8::URA3 kar1-1*                            *ρ^-S^5\`UTR~COX2~ ATP6 3\`UTR~COX2~ COX2*             This study
  RKY112                              *MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 arg8::HIS3*               *ρ^+^ atp6::ARG8m 5\`UTR~COX2~ATP6 3\`UTR~COX2~*       This study
  RKY172                              *MATα leu2∆ ura3-52 ade2-101 arg8::URA3 kar1-1*                            *ρ^-S^ atp6::GFP~β1-10~ COX2*                          This study
  RKY176                              *MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 arg8::HIS3*          *ρ^+^atp6::GFP~β1-10~ 5\`UTR~COX2~ATP6 3\`UTR~COX2~*   This study
  BiG Mito- Split-GFP                 *MATa his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 arg8::HIS3*                 *ρ^+^atp6::GFP~β1-10~ 5\`UTR~COX2~ATP6 3\`UTR~COX2~*   This study
  BiG Mito- Split- GFP+PAM16~β11ch~   *MATa his3-11,15 trp1-1::PAM16~β11ch~ leu2-3,112 ura3-1 CAN1 arg8::HIS3*   *ρ^+^atp6::GFP~β1-10~ 5\`UTR~COX2~ATP6 3\`UTR~COX2~*   This study
  BiG Mito- Split- GFP+PGK1~β11ch~    *MATa his3-11,15 trp1-1::PGK1~β11ch~ leu2-3,112 ura3-1 CAN1 arg8::HIS3*    *ρ^+^atp6::GFP~β1-10~ 5\`UTR~COX2~ATP6 3\`UTR~COX2~*   This study
  BiG Mito- Split- GFP+GUS1~β11ch~    *MATa his3-11,15 trp1-1:: GUS1~β11ch~ leu2-3,112 ura3-1 CAN1 arg8::HIS3*   *ρ^+^atp6::GFP~β1-10~ 5\`UTR~COX2~ATP6 3\`UTR~COX2~*   This study
  BY 4742                             *MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0*                                         *ρ^+^*                                                 [@bib73]

The BiG Mito-Split-GFP system restricts fluorescence emission to mitochondrially-localized proteins {#s2-2}
---------------------------------------------------------------------------------------------------

The BiG Mito-Split-GFP system was first tested with Pam16 which localizes in the matrix at the periphery of the mitochondrial inner membrane and Atp4, an integral membrane protein with domains exposed to the matrix ([@bib39]; [@bib70]; [Figure 2A](#fig2){ref-type="fig"}). The BiG Mito-Split-GFP host strain was transformed with centromeric plasmids expressing either Pam16~β11ch~ or Atp4~β11ch~ bearing the GFP~β11ch~ tag at their C-terminus under the constitutive GPD promoter. Expression of Pam16~β11ch~ and Atp4~β11ch~ resulted in strong GFP signal emissions that colocalized with MitoTracker Red CMXRos-stained mitochondria, whereas no fluorescence was detected with the corresponding empty plasmid ([Figure 2B](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). These observations confirmed that the GFP~β1-10~ polypeptide is well expressed from the mtDNA, stably and correctly folded, allowing reconstitution of an active GFP upon association with the mitochondrial GFP~β11ch~-tagged protein. So far, the positive controls we used for the proof of concept of the BiG Mito-Split-GFP approach are proteins more or less abundant: Atp4 (30000--40000 copies/cell) and Pam16 (3000 copies/cell) ([@bib49]; [@bib71]). We will report soon, in BioRxiv, tests with other proteins with a known mitochondrial location and varying abundance to better estimate the sensitivity of the BiG Mito-Split-GFP system, including the GatF subunit of the GatFAB tRNA-dependent amidotransferase chromosomally expressed from its own promoter. This is a mitochondrial protein that has been reported to be present at only 40--80 copies ([@bib71]).

We next tested the BiG Mito-Split-GFP system with a GFP~β11ch~-tagged version of Pgk1, which is commonly used as negative cytosolic marker protein to probe the purity of mitochondrial preparations. Pgk1~β11ch~ and endogenous Pgk1 were well detected by Western blot of total protein extracts probed with anti-Pgk1 antibodies ([Figure 2C](#fig2){ref-type="fig"}). No GFP fluorescence was observed with Pgk1~β11ch~ ([Figure 2B](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}) despite its good expression ([Figure 2C](#fig2){ref-type="fig"}). This is an interesting observation considering that Pgk1 localizes at the external surface of mitochondria ([@bib15]; [@bib41]; [@bib44]). This provides the proof that the BiG Mito-Split-GFP system does not yield any unspecific fluorescence with cytosolic proteins even when they are externally associated to the organelle (see also Source data 4). Another negative control (His3) that further confirms the absence of false positive signal will be provided soon in BioRxiv. In conclusion, these data show that any GFP~β11ch~-tagged protein that localizes inside the mitochondrial matrix or at matrix side periphery of the inner membrane triggers GFP reconstitution and fluorescence emission, making this emission a robust in vivo readout for the mitochondrial importability of proteins of nuclear genetic origin.

We next tested whether the BiG Mito-Split-GFP system also allows visualization of the mitochondrial echoform of a protein located in both the cytosol and the organelle. We chose the cytosolic glutamyl-tRNA synthetase (cERS) encoded by the *GUS1* gene as a proof of concept. As we have shown, cERS is an essential and abundant protein of the cytosolic translation machinery, and a small fraction (15%) is located in mitochondria where it is required for mitochondrial protein synthesis and ATP synthase biogenesis ([@bib20]; [@bib21]). After transformation of the BiG Mito-Split-GFP strain with plasmids expressing a GFP~β11ch~-tagged version of cERS under the control of either the GPD promoter (pGPD) or its own promoter (pGUS1), a GFP signal was observed only in mitochondria ([Figure 2B](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). We also generated a stable BiG Mito-Split-GFP strain in which the gene encoding cERS~β11ch~ was chromosomally expressed under the dependence of its own promoter at the *TRP1* locus ([Supplementary file 3](#supp3){ref-type="supplementary-material"}, [Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). Again, GFP fluorescence was strictly confined to mitochondria ([Figure 2B](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}). These observations demonstrate that the BiG Mito-Split-GFP system enables a specific detection in vivo of the mitochondrial pool of cERS (~mte~cERS), without any interference by the cytosolic echoform, which is not possible when cERS is tagged with regular GFP ([@bib20]). We also expressed Pam16~β11ch~ and Pgk1~β11ch~ under the dependence of the GPD promoter at the *TRP1* locus. Again, as shown with the plasmid-borne strategy, Pam16~β11ch~ expression resulted in a specific mitochondrial fluorescence, while Pgk1~β11ch~ gave no fluorescence ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}).

Using high-resolution Airyscan confocal microscopy, a typical 3D mitochondrial network was reconstituted from the fluorescence induced by the expression of Pam16~β11ch~, Atp4~β11ch~ and cERS~β11ch~ in the BiG Mito-Split-GFP strain whereas, as expected, no fluorescent at all was detected with Pgk1~β11ch~ ([Figure 2D](#fig2){ref-type="fig"}), which further illustrates the mitochondrial detection specificity of this system. These data were corroborated by flow cytometry analyses of the BiG Mito-Split-GFP strain stably expressing Pam16~β11ch~ and Pgk1~β11ch~ ([Figure 2E](#fig2){ref-type="fig"}). These data will soon be completed (in BioRxiv) with flow cytometry experiments aiming to know if the BiG Mito-Split-GFP system could be used in systematic screens for proteins with a mitochondrial localization.

We next evaluated whether the BiG Mito-Split-GFP approach represents a significant technical advance compared to the existing MTS-based Split-GFP methods that are currently used. To this end, we constructed cells (with a wild type mitochondrial genome) that co-express in the cytosol the mitochondrial protein GatF (with its own MTS) fused at its C-terminus with GFP~β1-10~ (mtGatF~β1-10~) and either cERS~β11ch~ (dual localized, positive control) or Pgk1~β11ch~ (cytosolic, negative control) ([Figure 2F](#fig2){ref-type="fig"}, left panel). As expected, a strong and specific mitochondrial fluorescent signal was obtained with cERS~β11ch~ ([Figure 2F](#fig2){ref-type="fig"}, right panel). However, Pgk1~β11ch~ resulted in a mitochondrial signal of similar intensity. This is presumably due to the location at the external surface of mitochondria of a small fraction of the Pgk1 pool that could interact with mtGatF~β1-10~ prior to its import into the organelle. These results show that due to the high affinity of both self-assembling Split-GFP fragments, the MTS-based strategy can generate a mitochondrial fluorescence without mitochondrial protein internalization ([Figure 2F](#fig2){ref-type="fig"}, right panel). These experiments suggest that compartment-restricted expression of the GFP~β1-10~ fragment and GFP~β11ch~-tagged proteins increases the reliability of identifying mitochondrial echoforms of dual-localized proteins.

Screening for mitochondrial relocation of cytosolic aminoacyl-tRNA synthetases {#s2-3}
------------------------------------------------------------------------------

Originally, screening cytosolic aminoacyl-tRNA synthetases (caaRSs) that can additionally relocate to mitochondria was motivated by several inconsistencies concerning this family of enzymes. The first and most documented example concerns cERS ([@bib20]; [@bib21]). We showed that the fraction of cERS which is imported (~mte~cERS) into mitochondria is essential for the production of mitochondrial Gln-tRNA^Gln^ by the so-called transamidation pathway ([@bib20]; [@bib21]). In the latter, ~mte~cERS aminoacylates the mitochondrial tRNA^Gln^ with Glu thereby producing the Glu-tRNA^Gln^ that is then converted into Gln-tRNA^Gln^ by the GatFAB amidotransferase (AdT) ([@bib20]; [@bib21]). These results argued against the proposal that mitochondrial import of cQRS compensates for the absence of nuclear-encoded mtQRS in yeast ([@bib58]). This being said, nothing excludes that cQRS can be imported into mitochondria to fulfill additional tasks beyond translation.

Another puzzling concern is the absence in *S. cerevisiae* of genes encoding six *stricto-senso* mtaaRSs: mtARS, mtCRS, mtGRS, mtHRS, mtQRS and mtVRS ([Table 2](#table2){ref-type="table"}). This suggests that the genes encoding their cytosolic equivalents (~cyte~caaRS) might also encode their mitochondrial echoforms (~mte~caaRSs). This has been confirmed for cARS, cGRS1, cHRS, cVRS for which alternative translation/transcription initiation allows the expression of both echoforms ([Figure 3D](#fig3){ref-type="fig"}; [@bib12]; [@bib13]; [@bib14]; [@bib50]; [@bib68]).

![Identification and visualization of mitochondrial echoforms of yeast cytosolic aaRSs using the BiG Mito-Split-GFP strategy.\
Fluorescence microscopy analyses of BiG Mito-Split-GFP strain transformed with pAG414pGPD~β11ch~ expressing yeast caaRSs (also see Table S3). Genes encoding 18 out of the 20 yeast caaRS, including those encoding the α- and β-subunits of the cytosolic α~2~β~2~ FRS (cFRS2), and the cGRS2 pseudogene, as well as the four encoding the cytosolic echoforms of cGRS1 (~cyte~cGRS1), cARS (~cyte~cARS), cHRS (~cyte~cHRS) and cVRS (~cyte~cVRS) were cloned in the pAG414pGPD~β11ch~ and expressed in the BiG Mito-Split-GFP strain (N = 2). (**A**) From the set of caaRSs tested, only cERS, cQRS, cFRS2 and ~cyte~cHRS micrographs are shown. (**B**) Table summarizing the GFP emission and mitochondrial localization of the caaRSs not shown in **A**). The corresponding micrographs are shown in Fig. S4A. (**C**) Fluorescence microscopy analysis of the BiG Mito-Split-GFP strain expressing the first 100 amino acids of the N-ter region of the cCRS fused to GFP~β11ch~ (N = 2). (**D**) Fluorescence microscopy analyses of BiG Mito-Split-GFP strain transformed with pAG414pGPD~β11ch~ expressing the mitochondrial echoforms ~mte~cGRS1, ~mte~cARS, ~mte~cHRS and ~mte~cVRS. Schematics of cARS, cGRS1, cHRS and cVRS echoforms expression in yeast. Expression can be initiated upstream of the initiator ATG~+1~ (~mte~cARS at ACG~-75~ and ~mte~cGRS1 at TTG~-69~) but the synthesis of this echoform can also be initiated at the ATG~+1~. In this case, the expression of the cytosolic echoform is initiated downstream (~cyte~cHTS at ATG~+60~ and ~cyte~cVRS at ATG~+148~). Mitochondria were stained with MitoTracker Red CMXRos. Scale bar: 5 µm. Representative fields are shown.\
Figure 3---source data 1.Confirmation, by WB, of the expression of the 18 full-length aaRS~β11ch~ and N100cCRS~β11ch~ in whole cell extracts from the transformed BiG Mito-Split-GFP strains (Related to [Figure 3](#fig3){ref-type="fig"}).Antibodies used for immunoblotting are indicated below WBs. Loading controls correspond to gels stained with the stain-free procedure.](elife-56649-fig3){#fig3}

###### List of genes encoding *S. cerevisiae* cytosolic and mitochondrial aminoacyl-tRNA synthetases and their cytosolic or mitochondrial echoforms

  --------------------------------------------------------------------------------------
         Gene coding for                                           
  ------ --------------------- ---------------- ------------------ ---------------------
  aaRS   cytosolic\            mitochondrial\   cytosolic (cyte)   mitochondrial (mte)
         (c)                   (mt)                                

  IRS    *ILS1*                *ISM1*           *-*                *-*

  GRS    *GRS1/GRS2*           *-*              *GRS1*             *GRS1 −23*

  SRS    *SES1*                *DIA4*           *-*                *-*

  KRS    *KRS1*                *MSK1*           *-*                *-*

  RRS    *RRS1*                *MSR1*           *-*                *-*

  ERS    *GUS1*                *MSE1*           *GUS1*             *GUS1*

  VRS    *VAS1*                *-*              *VAS1∆46*          *VAS1*

  YRS    *TYS1*                *MSY1*           *-*                *-*

  MRS    *MES1*                *MSM1*           *-*                *-*

  NRS    *DED81*               *SLM5*           *-*                *-*

  PRS    *YHR020W*             *AIM10*          *-*                *-*

  TRS    *THS1*                *MST1*           *-*                *-*

  DRS    *DPS1*                *MSD1*           *-*                *-*

  FRS    *FRS1 (β)/FRS2 (a)*   *MSF1 (a)*       *-*                *-*

  CRS    *CRS1*                *-*              *-*                *-*

  WRS    *WRS1*                *MSW1*           *-*                *-*

  QRS    *GLN4*                *-*              *-*                *-*

  ARS    *ALA1*                *-*              *ALA1*             *ALA1 −25*

  LRS    *CDC60*               *NAM2*           *-*                *-*

  HRS    *HTS1*                *-*              *HTS1∆20*          *HTS1*
  --------------------------------------------------------------------------------------

The *Saccharomyces* Genome Database standard gene names are used. The amino acid (aa) one-letter code is used for the aminoacyl-tRNA synthetase aa specificity and (-) means that the gene encoding the corresponding aaRS is missing. Two genes encode the cytosolic phenylalanyl-tRNA synthetase (cFRS) since the enzyme is an α~2~β~2~ hetero-tetramer. For echoforms, the position of the alternative initiation start codon is indicated and corresponds to the nomenclature described in [Figure 3](#fig3){ref-type="fig"}; briefly, (- number) means that the start codon of the ~mte~aaRS is located (number) aa upstream the one that starts translation of the corresponding ~cyte~aaRS while (∆number) means that the start codon of the ~cyte~aaRS is located (number) aa downstream the one that starts translation of the corresponding ~mte~aaRS.

We therefore applied the BiG Mito-Split-GFP strategy to the *S. cerevisiae* caaRSs (See [supplementary file 4](#supp4){ref-type="supplementary-material"}), aiming to discover new mitochondrial echoforms of caaRSs. We successfully expressed in the BiG Mito-Split-GFP strain the full length GFP~β11ch~-tagged versions of 18 out of 20 yeast caaRSs or ~cyte~aaRSs ([Figure 3A--C](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, [Supplementary files 3](#supp3){ref-type="supplementary-material"} and [4](#supp4){ref-type="supplementary-material"}). For unknown reasons, we failed to obtain the full-length GFP~β11ch~-tagged versions of cCRS and cPRS despite repeated attempts, but successfully cloned the first hundred N-terminal aa residues of cCRS (N~100~cCRS) ([Figure 3C](#fig3){ref-type="fig"}). An unambiguous mitochondrial fluorescent signal was observed with cFRS2~β11ch~ (the α-subunit of the α~2~β~2~ cFRS), ~cyte~cHRS~β11ch~ and N~100~cCRS~β11ch~ ([Figure 3A--C](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Since the existence of a fully functional mtFRS has been demonstrated ([@bib38]), it is possible that supernumerary ~mte~cFRS2 we identified is not necessary for charging mitochondrial tRNA^Phe^ but exerts some non-canonical functions, in addition to its role in cytosolic protein synthesis. The mitochondrial fluorescence triggered by expression of N~100~cCRS~β11ch~ suggests that this part of cCRS harbors a MTS, which has recently been proposed ([@bib51], see Discussion). The mitochondrial fluorescence triggered by ~cyte~cHRS~β11ch~ is more intriguing. The most plausible hypothesis is that the MTS of the ~mte~cHRS is longer than the one originally characterized. The other possibility is that there is indeed a second mitochondrial echoform of cHRS imported inside mitochondria through a cryptic MTS that has yet to be identified and, like for cFRS2, this new ~mte~cHRS would then most probably exert a non-canonical function.

As already mentioned, cARS, cGRS1, cHRS and cVRS genes are known to produce both cytosolic and mitochondrial forms of these proteins ([Figure 3D](#fig3){ref-type="fig"}). When ~mte~cARS~β11ch~, ~mte~cGRS1~β11ch~, ~mte~cHRS~β11ch~ and ~mte~cVRS~β11ch~ (echoforms that start with the most upstream methionine initiator codon, [Figure 3D](#fig3){ref-type="fig"}) were expressed in the BiG Mito-Split-GFP strain, a mitochondrial GFP staining was, as expected, observed with these four ~mte~caaRSs ([Figure 3D](#fig3){ref-type="fig"}). Conversely, ~cyte~cARS~β11ch~, ~cyte~cGRS1~β11ch~ and ~cyte~cVRS~β11ch~, versions without their MTS) did not produce any detectable GFP signal confirming the MTS-dependency of these cytosolic echoforms for mitochondria localization ([Figure 3D](#fig3){ref-type="fig"}; [Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}). The mitochondrial fluorescence produced by ~cyte~cHRS~β11ch~ has already been discussed above.

Investigating non-conventional mitochondrial targeting signals in dual localized proteins {#s2-4}
-----------------------------------------------------------------------------------------

Unlike proteins with a MTS that is cleaved upon import into mitochondria, ~mte~cERS does not involve any processing ([@bib20]). Presumably, the mitochondrial targeting residues are located in the N-terminal (N-ter) region of cERS as in precursors of mitochondrial proteins destined to the matrix. To identify them, we tagged with GFP~β11ch~ three N-ter domains of cERS of varying length that correspond to the first 30 (cERS~β11ch~-N1), 70 (cERS~β11ch~-N2) and 200 (cERS~β11ch~-N3) residues of cERS ([Supplementary files 3](#supp3){ref-type="supplementary-material"} and [4](#supp4){ref-type="supplementary-material"}; [Figure 4A](#fig4){ref-type="fig"}) and we tested their ability to be imported in the mitochondria of the BiG Mito-Split-GFP strain ([Figure 4B](#fig4){ref-type="fig"}). All three peptides produced a GFP fluorescence signal that matched the labeling of mitochondria with MitoTracker Red CMXRos ([Figure 4B](#fig4){ref-type="fig"}). Consistently, no GFP fluorescence was detected with cERS~β11ch~ lacking the residues 1--30 or 1--200 (cERS~β11ch~-∆N1 and cERS~β11ch~-∆N2 respectively) ([Figure 4B](#fig4){ref-type="fig"}) despite detection by WB of these truncated proteins in cells ([Figure 4C](#fig4){ref-type="fig"}). For unknown reasons, cERS~β11ch~-N1 and cERS~β11ch~-N2 constructs were not detected by Western blot but gave a proper mitochondrial fluorescence staining ([Figure 4B](#fig4){ref-type="fig"} and **C**). These data narrow down cERS' MTS to the 30 first aa residues of its N-ter domain; this segment is made of a short β-strand and a 13 aa long α-chain ([@bib64]) likely harboring the import signal. This further illustrates the strength of our technique towards the identification of unconventional MTSs in dual localized proteins.

![The BiG Mito-Split-GFP is a suitable tool to delimit regions containing non-canonical MTSs.\
(**A**) Schematic representation of the cERS fragments fused to GFP~β11ch~. Orange boxes correspond to the GST-like domain necessary for Arc1 interaction (GST), the grey boxes represent the catalytic domain (CD), and the blue box, the tRNA-binding domain generally named anti-codon binding domain (ABD). Numbering above corresponds to cERS amino acids residues. (**B**) Fluorescence microscopy analyses of the BiG Mito-Split-GFP strain expressing the cERS variants shown on **A**. Mitochondria were stained with MitoTracker Red CMXRos; scale bar: 5 µm. The secondary structure (according to [@bib64]) of the smallest peptide that still contains the non-conventional MTS of cERS is described together with the amino acid sequence of each helices. Positively and negatively charged amino acids are shown in orange and blue respectively. (**C**) Immunodetection of the cERS variants in BiG Mito-Split-GFP whole cell extracts using anti-GFP antibodies. Quantity of proteins loaded in each lane was estimated using anti-Pgk1 antibodies or by the stain-free procedure. The bands corresponding to the mutants N1 and N2 could not be detected. The representative fields or gel are shown.\
Figure 4---source data 1.Immunodetection of the cERS variants in BiG Mito-Split-GFP whole cell extracts using anti-GFP antibodies (related to [Figure 4C](#fig4){ref-type="fig"}).Antibodies used for immunoblotting are indicated below WBs. Loading controls correspond to gels stained with the stain-free procedure.](elife-56649-fig4){#fig4}

Testing mitochondrial importability of plant and mammalian proteins using the BiG Mito-Split-GFP system {#s2-5}
-------------------------------------------------------------------------------------------------------

The BiG Mito-Split-GFP system is based on modifications in the mitochondrial genome for expressing the GFP~β1-10~ fragment inside the organelle. Modifying the mitochondrial genome is thus far only possible in *S. cerevisiae* and *Chlamydomonas reinhardtii* ([@bib56]). Owing to the high degree of conservation of mitochondrial protein import systems ([@bib47]), we used the yeast BiG Mito-Split-GFP strain to test the mitochondrial importability of proteins from various eukaryotic origins. We first tested two glutamyl-tRNA synthetases from *Arabidopsis thaliana*, *Ath*cERS and *Ath*mt/chlERS. According to independent MTS prediction tools, *Ath*cERS would be a cytosolic protein with a putative chloroplastic targeting signal (TargetP1.1), whereas *Ath*mt/chlERS is strongly predicted to be located in mitochondria and chloroplast ([Figure 5A](#fig5){ref-type="fig"}). cDNAs encoding the *Ath*cERS and *Ath*mt/chlERS proteins were fused to GFP~β11ch~ ([Supplementary files 3](#supp3){ref-type="supplementary-material"} and [4](#supp4){ref-type="supplementary-material"}) and the resulting plasmids were transformed into the BiG Mito-Split-GFP strain. Expression of these proteins was confirmed by Western blot ([Figure 5C](#fig5){ref-type="fig"}). *Ath*cERS~β11ch~ did not produce any GFP signal, whereas consistent with its predicted localization *Ath*mt/chlERS~β11ch~ resulted in a specific mitochondrial fluorescence staining ([Figure 5B](#fig5){ref-type="fig"}). These data show that the yeast BiG Mito-Split-GFP system can be used to analyze mitochondrial localization of plant proteins.

![The BiG Mito-Split-GFP can be used to study mitochondrial importability of mammalian and plant proteins.\
(**A, D**) Prediction of MTS and mitochondrial localization of (**A**) two ERS from *Arabidopsis thaliana* (*Ath*cERS and *Ath*mt/chlERS) and (**D**) five eukaryotic Ago2 proteins \[*Hsa*Ago2 (Protein argonaute-2 isoform X2 \[Homo sapiens\] NCBI sequence ID: XP_011515267.1), *Mmu*Ago2 (protein argonaute-2 *Mus musculus* NCBI sequence ID: NP_694818.3.), *Bta*Ago2 (*Bos Taurus*), D*re*Ago2 (*Danio rerio*), *Dme*Ago2 (*Drosophila melanogaster*). MTS were predicted using TPpred2.0 (<http://tppred2.biocomp.unibo.it/tppred2>), TargetP1.1 (<http://cbs.dtu.dk/services/TargetP/>), MitoFates (<http://mitf.cbrc.jp/MitoFates/cgibin/top.cgi>) and the EukmPloc2 website (<http://www.csbio.sjtu.edu.cn/bioinf/euk-multi-2/>). Grey boxes indicate prediction of a cytosolic localization, light and dark green indicate prediction of mitochondrial or chloroplastic localization respectively. Blue boxes indicate prediction of nuclear localization. (**B, E**) Fluorescence microscopy analyses of the BiG Mito-Split-GFP strain expressing the GFP~β11ch~-tagged *~Ath~*cERS and *~Ath~*mt/chlERS (N = 2) (**B**) and~*Mmu*~Ago2, *~Hsa~*Ago2 (N = 2) (**E**). Mitochondria were stained with MitoTracker Red CMXRos. Scale bar: 5 µm. Representative fields are shown. (**C, E**) Protein expression was checked by WB with anti-GFP antibodies and equal amount of loaded protein was controlled using anti-Pgk1 antibodies and by the stain-free technology (Loading control: stain-free). The representative gels are shown.\
Figure 5---source data 1.Confirmation, by WB, of the expression of AthERS~β11ch~ and mouse and human Ago2~β11ch~ in whole cell extract from the transformed BiG Mito-Split-GFP strains (Related to [Figure 5C and F](#fig5){ref-type="fig"}).Antibodies used for immunoblotting are indicated below WBs. Loading controls correspond to gels stained with the stain-free procedure.](elife-56649-fig5){#fig5}

We also used the BiG Mito-Split-GFP system to address a yet-unresolved question regarding the presence of mammalian Argonaute protein 2 (Ago2) in mitochondria. This protein mainly localizes to the nucleoplasm and cell junctions where it is required for RNA-mediated gene silencing (RNAi) by the RNA-induced silencing complex (RISC) ([@bib26]). In some studies, Ago2 was suggested to be associated to mitochondria, but it remains unclear whether it localizes at the external surface or inside the organelle ([@bib3]; [@bib62]). Using four different algorithms a potential MTS could not be predicted in Ago2 proteins from human, mouse, *Bos taurus*, *Danio rerio* and*Drosophila melanogaster*, casting doubts on the mitochondrial import of Ago2 ([Figure 5D](#fig5){ref-type="fig"}). To help resolve this question, the BiG Mito-Split-GFP yeast strain was transformed with plasmids expressing mouse and human Ago2~β11ch~ proteins (*Mmu*Ago2~β11ch~ and *Hsa*Ago2~β11ch~, respectively, [Supplementary files 3](#supp3){ref-type="supplementary-material"} and [4](#supp4){ref-type="supplementary-material"}). Expression of each of these GFP~β11ch~-tagged constructs was confirmed by WB, and both generated a solid and specific GFP fluorescence restricted to mitochondria ([Figure 5E and F](#fig5){ref-type="fig"}). These observations provide strong evidence that in addition to a cytosolic and nuclear location, Ago2 is also transported into mitochondria and is really a multi-localized protein with a mitochondrial echoform.

Discussion {#s3}
==========

Initially designed to study protein-protein interactions and solubility, the Split-GFP technology was almost immediately hijacked to track protein localization in various cell types and compartments ([@bib29]; [@bib31]; [@bib33]; [@bib42]; [@bib53]; [@bib69]). It has also been used to study the mitochondrial localization of *PARK7* upon nutrient starvation ([@bib10]), and to detect remodeling of MERCs (mitochondria-ER contact sites) in mammalian cells ([@bib75]). Recently, Kakimoto and coworkers developed in yeast and mammalian cells a Split-based system to analyze inter-organelles contact sites ([@bib32]). However, in these approaches both GFP~β1-10~ and GFP~β11~ were anchored to proteins either translated in the cytosol or following the secretory pathway. Although the latter may avoid nonspecific interaction or reconstitution of the two GFP parts, we bring herein proofs that the simultaneous synthesis of both fragments in the cytosol, coupled to their high affinity to self-assemble, may induce potential false-positive GFP emission ([Figure 2F](#fig2){ref-type="fig"}).

To bypass this issue, we describe herein a new and robust Split-GFP system where the first 10 segments of beta barrel GFP (GFP~β1-10~) is expressed from the mitochondrial genome and translated inside the organelle without interfering with mitochondrial function ([Figure 1C and D](#fig1){ref-type="fig"}). The remaining beta barrel is concatenated (GFP~β11ch~), tagged to the protein of interest and expressed from cytosolic ribosomes. As a result, any detected GFP fluorescence obligatory originates from the organelle thereby demonstrating a mitochondrial localization for the tested proteins ([Figure 6A--B](#fig6){ref-type="fig"}).

![Schematic of the BiG Mito-Split-GFP system and its applications.\
(**A**) Using our engineered strain, we could show the dual localization of echoforms in the aaRS family of proteins and foster its power by studying localization of heterologous proteins originating from plants, mice and human. (**B**) The BiG Mito-Split-GFP strain was generated by integrating the sequence encoding the first 10 beta barrel segments into yeast mitochondrial DNA, and by either expressing any protein of interest fused to the 11^th^ GFP segment from a plasmid or by integration in yeast nuclear DNA. As opposed to regular GFP-tagging where visualizing an echoform ultimately results in a GFP signal diffusing in the entire cell, our BiG Mito-Split-GFP system abolishes the fluorescence originating from cytosolic echoform to only display a specific mitochondrial signal. Further applications range from high-throughput experiments to identify relocating proteins involved in mitochondria homeostasis or metabolism, to identify non-conventional MTSs or seek for mitochondrial localization of heterologous proteins.](elife-56649-fig6){#fig6}

This system was first successfully tested with two mitochondrial proteins (Atp4 and Pam16), and a cytosolic one (Pgk1) as a negative control. Moreover, the mitochondrial echoform of the cytosolic glutamyl-tRNA synthetase (~mte~cERS) encoded by the *GUS1* nuclear gene was also detected with the BiG Mito-Split-GFP system ([Figures 2](#fig2){ref-type="fig"}, [3](#fig3){ref-type="fig"}, [4](#fig4){ref-type="fig"} and [6A](#fig6){ref-type="fig"}). As we already showed, synchronous release of cERS and cMRS from the cytosolic anchor Arc1 protein is required for a coordinated expression of mitochondrial and nuclear ATP synthase genes ([@bib20]; [@bib21]). Mitochondrial relocation of cERS is consistent with the functional plasticity of caaRSs with multiple locations in cells. Using GFP~β11ch~-tagged N-ter segments of cERS, we localized its cryptic MTS within the first 30 aa residues. This region lacks amphiphilic residues (residues 15--28) and folds into a β-strand-loop-α−helix motif different than regular MTSs ([@bib59]; [@bib64]; [Figure 4](#fig4){ref-type="fig"}). These findings demonstrate that the BiG Mito-Split-GFP system allows not only to visualize in living cells the mitochondrial pool of proteins with multiple cellular locations, but also to decipher their non-conventional MTSs.

Recent efforts made to identify mitochondrial proteins and assign their submitochondrial localization revealed an exquisite precision ([@bib49]). However, resolving mitochondrial proteomes is challenging due to the difficulty of obtaining pure mitochondria and because many proteins transiently localize in mitochondria and are found elsewhere in cells. Up to 10--20% of the yeast mitoproteome was suggested to be composed of proteins with another location in cells (*i.e* the cytosol, the nucleus, ER...) ([@bib6]; [@bib49]). Our BiG Mito-Split-GFP system will be especially helpful to resolve these proteome complexities. This system was here applied to proteins involved in tRNA aminoacylation, some of which are well-known to relocate in different compartment to fulfill a wide range of cellular activities ([@bib27]; [@bib37]; [@bib74]). In this way, we provide strong evidence that cFRS2 and ~cyte~cHRS are dual localized as was observed for cERS, which suggests that these proteins may have additional roles beyond translation ([Figure 6A](#fig6){ref-type="fig"}). Being dually localized in the cytosol and mitochondria, and since there is no ~mte~cFRS1, it can be inferred that the catalytic α-subunit (cFRS2) is not inevitably in complex with the β-subunit within the α~2~β~2~ heterotetrameric form of cFRS. It will be interesting to test whether these findings in yeast extend to heterotetrameric cFRS from other eukaryotes, including humans. A *bona fide* mtFRS (encoded by the *MSF1* gene) that was shown to function as a monomer is essential to generate mitochondrial Phe-tRNA^Phe^ (F-~mt~tRNA^F^) in mitochondria ([@bib60]). This further supports the hypothesis that ~mte~cFRS2 is not required to produce F-~mt~tRNA^F^ but more likely has a non-canonical yet-to-be-discovered function. Our failure to detect a mitochondrial echoform for cQRS is consistent with our previous findings ([@bib20]) that the only source of Q-~mt~tRNA^Q^ in mitochondria is provided by the relocation of ~mte~cERS into the organelle ([Figure 3](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) *de concert* with the tRNA-dependent GatFAB Adt ([@bib21]). This definitely casts in doubt the previous proposal of the existence of a cQRS mitochondrial echoform ([@bib58]). In agreement with our results ([Figure 3C](#fig3){ref-type="fig"}), mitochondrial echoforms of cCRS were also detected in a recent study and shown to result from alternative transcription and translation starts ([@bib51]), thereby unraveling how mtCRS is expressed from the *CRS1* gene and rationalizing how mitochondrial Cys-tRNA^Cys^ is produced.

Having identified new mitochondrial echoforms of caaRSs, we wondered if they carry in their N-terminal regions some common specific sequence or structural features possibly driving mitochondrial import. No specific motif was found using MAST/MEME analysis ([@bib1]), and there was no significant sequence similarity (as tested with Blast) ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). All but ~mte~cARS show at least one α−helix within their 50 first aa residues, and most (except cERS) are enriched in positively- vs negatively-charged aa residues, as in classical mitochondrial targeting sequences. Due to the lack of 3D structures, we cannot rule out that these N-termini adopt some specific ternary structure that are important for mitochondrial localization. As we have shown, most of the cytosolic form of cERS interacts with Arc1 in fermenting yeast, but during the diauxic shift, Arc1 expression is repressed, allowing the generation of a free pool of cERS able to relocate into mitochondria. Thus, in the case of this caaRS, interactions of its N-terminal domain seem to be important to distribute it between the cytosol and mitochondria. Future work is required to know whether such a mechanism operates also for the other dually localized caaRSs.

Our BiG Mito-Split-GFP system requires modifications of the mitochondrial genome, which can be achieved in only a limited number of organisms (*S. cerevisiae *[@bib7] and *C. Reinhardtii* [@bib56]). However, due to the good evolutionary conservation of mitochondrial protein import, we reasoned that the system we developed in yeast could be used to test proteins of various eukaryotic origins, and we present evidence that this is indeed the case ([Figure 5](#fig5){ref-type="fig"}; [Figure 6C](#fig6){ref-type="fig"}). For instance, we showed that the mammalian Ago2 protein (*Hsa*- and *Mmu*Ago2, [Figure 5](#fig5){ref-type="fig"}) heterologously-expressed in yeast localize inside mitochondria. This protein was suggested to be exclusively located at the external surface of mitochondria in human cells where it would help the transport of pre- and miRNAs into the organelle, as do numerous nuclear-encoded pre- and miRNAs ([@bib2]; [@bib3]; [@bib40]). Several studies have suggested that mitochondrial miRNAs, also termed mitomiRs, play a role in apoptosis ([@bib40]), mitochondrial functions ([@bib16]), and translation ([@bib2]; [@bib30]; [@bib45]; [@bib76]), and this would require the mitochondrial import of Ago2 ([@bib2]; [@bib16]; [@bib30]; [@bib45]; [@bib76]). However, the import of mitomiRs is still poorly understood and several possible import mechanisms have been evoked ([@bib3]; [@bib62]). Our unambiguous detection of Ago2 inside mitochondria of yeast cells expressing this protein sheds new light on its potential role in miRNAs import.

The yeast BiG Mito-Split-GFP system we describe here is designed to point out mitochondrial echoforms. It is robust, not expensive and can be used to test proteins from various organisms. This new approach has certainly many potential applications and opens new avenues in the study of mitochondria and their communications with other compartments of the cell.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                       Designation                                               Source or reference   Identifiers         Additional information
  (species) or resource                                                                                                                   
  ----------------------------------- --------------------------------------------------------- --------------------- ------------------- -------------------------------------------------------------------------------
  Genetic reagent (*S. cerevisiae*)   BiG Mito- Split-GFP                                       This study                                RKY176 strain with *ADE2* gene\
                                                                                                                                          (*ρ^+^atp6::GFP~β1-10~5\`UTR~COX2~ ATP6 3\`UTR~COX2~*)

  Genetic reagent (*S. cerevisiae*)   BiG Mito- Split-GFP+Pgk1~β11ch~                           This study                                RKY176 strain (*PGK1:: β11ch::TRP1*)

  Genetic reagent (*S. cerevisiae*)   BiG Mito- Split-GFP+PAM16~β11ch~                          This study                                RKY176 strain (*PAM16:: β11ch::TRP1*)

  Genetic reagent (*S. cerevisiae*)   BiG Mito- Split-GFP+cERS~β11ch~                           This study                                RKY176 strain (*GUS1:: β11ch::TRP1*)

  Antibody                            Anti-GFP (Mouse polyclonal)                               Sigma                 Cat\# G1544         WB (1:5000)\
                                                                                                                                          Called GFP N-ter in [Figure 2C](#fig2){ref-type="fig"} recognizes GFPβ1--10

  Antibody                            Anti-GFP (Mouse monoclonal IgG~1~κ clones 7.1 and 13.1)   Roche                 Cat\# 11814460001   WB (1:5000)\
                                                                                                                                          Called GFP polyclonal in [Figure 2C](#fig2){ref-type="fig"} recognizes GFPβ11

  Antibody                            Anti-Pgk1 (Mouse monoclonal IgG1, clone 22C5D8)           Molecular Probes      Cat\# 459250        WB (1:5000)

  Recombinant DNA reagent             pAG414-p*GPD*- β11ch (plasmid)                            This study                                Template vector used for all constructs. Cloning done by Gibson assembly

  Chemical compound, drug             MitoTracker Red CMXRos                                    ThermoFisher          Cat\# M7512         Mitochondria staining

  Chemical compound, drug             0.5% (v/v) 2,2,2-Trichloroethanol                         Sigma                 Cat\# T54801        Used to detect total protein loading in SDS-PAGE, referred to Loading control
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Construction of plasmids {#s4-1}
------------------------

*ATP6* gene flanked by 75 bp of 5\`UTR and 118 bp of 3\`UTR of *COX2* was synthesized by Genescript and cloned at the EcoRI site of pPT24 plasmid bearing the sequence of *COX2* gene along with its UTRs ([@bib66]), giving pRK49-2. The *GFP~β1-10~* sequence (optimized for mitochondrial codon usage) encoding the first ten β-strands of GFP flanked by the regulatory sequences of *ATP6* gene and BamHI/EcoRI sites was synthesized by Genescript. The BamHI-EcoRI DNA fragment was cloned into pPT24 plasmid, giving the pRK67-2. The sequences of inserts were verified by sequencing.

The *GFP~β11ch~* coding sequence, synthesized by Genescript, was subcloned into the pAG414 pGPD-ccdB vector to generate the pAG414pGPD-ccdB~β11ch~. All genes encoding cytosolic or mitochondrial proteins were amplified from genomic DNA using the PrimeSTAR Max polymerase according to the manufacturer instructions (Takara), purified by PCR clean up (Macherey-Nagel) and subcloned either by Gateway (Thermofisher) ([@bib34]) or Gibson assembly (NEB) ([@bib23]; [@bib22]) according to the manufacturer's instructions (see Table S2).

Construction of the BiG Mito-Split-GFP strain {#s4-2}
---------------------------------------------

The genotypes of strains used in this study are listed in [Table 1](#table1){ref-type="table"}. The ρ^+^ indicates the wild-type complete mtDNA (when followed by deletion/insertion mutation it means the complete mtDNA with a mutation). The ρ^-^ synthetic genome (ρ^-S^) was obtained by biolistic introduction into mitochondria of ρ^0^ DFS160 strain (devoid of mitochondrial DNA) of the plasmids (pRK49-2 or pRK67-2) bearing indicated genes. The integration of *ATP6* gene into the mtDNA under the control of regulatory sequences of *COX2* was done using a previously described procedure ([@bib65]). The pRK49-2 plasmid was introduced into mitochondria of DFS160 ρ^0^ strain by ballistic transformation using the Particle Delivery Systems PDS-1000/He (*BIO-RAD*) as described ([@bib7]), giving the ρ^-S^ strain RKY89. For the integration of the *ATP6* gene at the *COX2* locus, we first constructed a ρ^+ ^strain (RKY83, Fig. S2A) with a complete deletion of the coding sequence of *ATP6* (*atp6::ARG8m*) and a partial deletion in *COX2*, *cox2-62* ([Table 1](#table1){ref-type="table"}), by crossing YTMT2 (Matα derivative of strain NB40-3C carrying the *cox2-62* mutation ([@bib65]) and MR10 (*atp6::ARG8m*) ([@bib54]). After crossing, cells were allowed to divide during 20--40 generations to allow mtDNA recombination and mitotic segregation of the double mutation. The double *atp6::ARG8m cox2-62* mutant colonies were identified by crossing with the ρ^-S^ strain SDC30 ([@bib18]) that carries *ATP6* and *COX2* which restored the respiratory competence and by crossing with the YTMT2 strain, ρ^+^*cox2-62*, which did not restored the respiratory competence of the double mutant. Next, the ρ^-S^ strain RKY89 was crossed with strain RKY83. This cross resulted in the respiratory competent progenies, named RKY112, which were growing on minimal medium without arginine ([Table 1](#table1){ref-type="table"}, [Figure 1B](#fig1){ref-type="fig"} and S2B). The ectopic integration of the *ATP6* gene into *COX2* locus was verified by PCR using oligonucleotides oAtp6-2, oAtp6-4, o5\`UTR2 and o5\`UTR1 (Table S1, Fig. S2D). To integrate *GFP~β1-10~* into *ATP6* locus the ρ^-S^ strain RKY172 was obtained by biolistic transformation of DFS160ρ^0^ with pRK67-2, as described above. RKY172 was crossed with RKY112, heterokaryons were allowed to divide during 20--40 generations to allow mtDNA recombination and mitotic segregation (Fig. S2C). The RKY176 progenies were selected by their respiratory competence and inability to grow on arginine depleted plates. The correct integration of the *GFP~β1-10~* gene into *ATP6* locus was verified by PCR using oligonucleotides oAtp6-1, oAtp6-10, oXFP-pr and oXFP-lw (Table S1, Fig. S2E). Finally, *ADE2* WT sequence was amplified from the genomic DNA of a BY strain using oligonucleotides *ADE2* Fw and *ADE2* Rv (Table S2) and transformed into the RKY176 strain. Red/white colonies were then screened on adenine depleted plates to select *ADE2*-bearing RK176 strain.

Media and growth conditions {#s4-3}
---------------------------

Yeast cell culture media and their composition: complete glucose YP medium (1% Bacto yeast extract, 1% Bacto peptone, 2% glucose, 40 mg/l adenine), complete YP Gal (1% Bacto yeast extract, 1% Bacto peptone, 2% galactose, 40 mg/l adenine), synthetic media composed of 0.67% (w/v) yeast nitrogen base without amino acids (aa), 0.5% (w/v) ammonium sulfate, either 2% (w/v) glucose (SC), galactose (SC Gal) or glycerol (SC Gly) and a mixture of aa and bases from Formedium (Norfolk, UK). Low sulfate medium LSM contained 0.67% (w/v) yeast nitrogen base without aa and ammonium sulphate, 2% galactose and 50 mg/L histidine, tryptophan, leucine, uracil, adenine, and arginine. The solid media contained 2% (w/v) of agar. Every strain was grown at 30°C with rotational shaking to mid-log (OD~600\ nm ~= 0.7). SC Gal was filtered on 25 µm filters and not autoclaved before use.

Pulse-labelling of mitochondrially-synthesized proteins and ATP synthesis {#s4-4}
-------------------------------------------------------------------------

Labeling of mitochondrial translation products was performed using the protocol described by [@bib4]. Yeast cells were grown to early exponential phase (10^7^ cells/mL) in 10 mL of liquid YP Gal medium. Cells were harvested by centrifugation and washed twice with LSM medium then suspended in the same medium and incubated for cysteine and methionine starvation for 2 hr at 28°C with shaking. Cells were suspended in 500 µL of LSM medium, and 1 mM cycloheximide was added. After a 5 min incubation at 28°C, 0.5 mCi of \[^35^S\]methionine and \[^35^S\]cysteine (Amersham Biosciences) was added and cell suspension was further incubated for 20 min at 28°C. Total proteins were isolated by alkaline lysis and suspended in 50 µL of Laemmli buffer. Samples with the same level of incorporated radioactivity were separated by SDS-PAGE in 17.5% (w/v) acrylamide gels (to separate Atp8 and Atp9) or 12% (w/v) acrylamide containing 4 M urea and 25% (v/v) glycerol (to separate Atp6, Cox3, Cox2 and cytochrome b). After migration, the gels were dried and \[^35^S\]-radiolabeled proteins were visualized by autoradiography with a PhosphorImager after a one-week exposure. To measure ATP synthase activities in the RKY112 strain, mitochondria were prepared by the enzymatic method as described in [@bib25]. For the rate of ATP synthesis, the mitochondria (0.15 mg/mL) were placed in a 1 mL thermostatically controlled chamber at 28°C in respiration buffer (0.65 M mannitol, 0.36 mM EGTA, 5 mM Tris-phosphate, 10 mM Tris-maleate pH 6.8) ([@bib57]). The reaction was started by adding 4 mM NADH and 750 µM ADP; 100 µL aliquots were taken every 15 s and the reaction was stopped by adding 3.5% (v/v) perchloric acid and 12.5 mM EDTA. Samples were neutralized to pH 6.5 by KOH and 0.3 M MOPS. ATP was quantified using the Kinase-Glo Max Luminescence Kinase Assay (Promega) and a Beckman Coulter\'s Paradigm Plate Reader.

Flow cytometry analysis {#s4-5}
-----------------------

5 mL of cells stably expressing Pam16~β11ch~ and Pgk1~β11ch~ strains (see [Table 1](#table1){ref-type="table"}) grown in YPD to confluence were diluted in 4 mL of SC Gal and grown overnight to reach mid-log phase. They were then diluted again in SC Gal and grown for 6 hr. Cells were then centrifuged and resuspended in water, passed for GFP detection on a BD FACS Canto II cytometer and Data analysis was performed using FlowJo.

Proteins extraction and western blots {#s4-6}
-------------------------------------

10 mL of cells grown to mid-log phase were harvested and spin down 5 min at 2000 *× g* at room temperature (RT). Cells were suspended in 500 µL of deionized water, 50 µL of 1.85 M NaOH was added and the mixture was incubated 10 min on ice. After addition of 50 µL of TCA 100% and 10 min of incubation on ice, the total precipitate was pelleted by centrifugation 15 min at 13000 *× g* at 4°C. After removing the supernatant, pellets were suspended in 200 µL of Laemmli buffer (1×) supplemented with 20 µL of 1M Tris Base pH 8.

For each strain, 10 µL of total proteins were separated by SDS-PAGE on 8-, 10- or 12% (w/v) polyacrylamide gels prior to electroblotting with a Trans-Blot Turbo system (*BIO-RAD*) onto PVDF membranes (*BIO-RAD*, \#1704156). Detection was carried out using mouse monoclonal IgG anti-GFP primary antibodies (1:5000; Roche Clone 7.1 and 13.1) + mouse polyclonal for the recognition of GFP~β1-10~ (1:5000, Sigma \#G1544), and mouse monoclonal IgG1 anti-Pgk1 primary antibodies (1:5000; Molecular Probes Clone 22C5D8). Secondary antibodies were Goat anti-mouse IgG (H+L) HRP-conjugated antibodies (*BIO-RAD*; \#1706516), at a concentration of 1:10000. ECL-plus reagents (*BIO-RAD*) was used according to the manufacturer's instructions and immuno-labeled proteins were revealed using a ChemiDoc Touch Imaging System (*BIO-RAD*). Total load of protein (Loading control) was assessed by UV detection using a ChemiDoc Touch Imaging System (*BIO-RAD*; Stain-free procedure) and detected by addition of 0.5% (v/v) 2,2,2-Trichloroethanol (Sigma \#T54801) to the 30% acrylamide/bis-acrylamide solution.

Image acquisition and staining {#s4-7}
------------------------------

Cells were incubated overnight in the appropriate media, diluted to an OD~600\ nm~ of 0.3 prior to microscopy studies and stained after 6 hr of growth at 30°C. For mitochondria staining, cells were centrifuged 1 min at 1500 *× g* at room temperature, suspended in 1 mL of SC Gal supplemented with Red-Mitotracker CMXRos at a final concentration of 100 nM (Molecular Probes), and incubated 15 min at rotational shaking at 30°C. Cells were washed three times in one volume of deionized water, and suspended in 100 µL of deionized water for microscopic studies. Epifluorescence images were taken with an AXIO Observer d1 (Carl Zeiss) epifluorescence microscope using a 100 × plan apochromatic objective (Carl Zeiss) and processed with the Image J software. Images for 3D reconstruction were taken using a confocal LSM 780 high resolution module Airyscan with a 63 × 1.4 NA plan apochromatic objective (Carl Zeiss) controlled by the Zen Black 2.3 software (Carl Zeiss). Z-stack reconstruction was performed on the IMARIS 9.1.2 (Bitplane AG) software.
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###### Sequence of the BamHI-EcoRI DNA fragment of GFP~β1-10~ flanked by the regulatory sequences of *ATP6* gene Regulatory sequences of ATP6 are underlined, 5'-BamHI and 3'-EcoRI sites are in italicized bold characters.

The GFP~β1-10~ sequence is in gray background and has been codon-optimized to be expressed by *S. cerevisiae* mitochondrial translation machinery.

###### Primers used in the study to verify integration of ectopic *ATP6* or *GFP~β1-10~* in mtDNA.

The use of each oligo is described in the Materials and methods section.

###### Primers used for PCR amplifications of genes fused to GFP~β11ch~ sequence.

The primers in black and blue were used for Gateway and Gibson cloning methods respectively (see Material and methods section).

###### List of expression plasmids generated for this study.
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Source data for all figures showing blots and microscopy images have been provided.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

We are excited to publish this paper as we feel that this work describes a long awaited, \"ultimate\" version of the split-GFP technique for the study of mitochondrial import. The presented data clearly shows that the method works and is widely applicable in the field of mitochondrial biology. The work presents a masterful use of yeast genetics and makes a very significant contribution to the field.

**Decision letter after peer review:**

Thank you for submitting your article \"Assigning mitochondrial localization of dual localized proteins using a yeast Bi-Genomic Mitochondrial-Split-GFP\" for consideration by *eLife*. We are happy to say that we find your article suitable for publication following some required revisions.

Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Dominique Soldati-Favre as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in *eLife* but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.

Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in *eLife*, either of which would be linked to the original paper.

Please find below a summary of the points agreed upon by the reviewers and the reviewing editor:

Summary

The work by Bader et. al presents a new bigenomic fluorescent complementation reporter (BiG Mito-Split-GFP) for assessing the mitochondrial localization of dually localized proteins. First, the authors describe the creation of the reporter. Using an intricate yeast genetics approach the authors integrated a larger part (β-sheets 1-10) of the split-GFP coding sequence into the yeast mitochondrial genome. The smaller part of the split-GFP (β-sheet 11) was fused to a number of studied proteins on plasmids. Second, the authors demonstrate that the reporter correctly shows the localization of known mitochondrial proteins and gives no/little signal for a protein which is only cytosolic. The described BiG Mito-Split-GFP reporter is compared with an available method in which both split-GFP components are encoded in the nuclear genome and the BiG Mito-Split-GFP is shown to be superior. Then the authors demonstrate the application of their technique to the study of mitochondrial echoforms of amino acid tRNA synthetases (aaRSs). They discover a new echoform for phenylalanine aaRS and look into the targeting signal for glutamate aaRS mitochondrial echoform. Finally, the application for the study of mitochondrial import of heterologous proteins from animals, plants and algae is shown. For instance, the authors demonstrate that Ago2 protein from mammals has a capacity to be imported into yeast mitochondria. This work describes a long awaited, \"ultimate\" version of the split-GFP technique for the study of mitochondrial import. The presented data clearly shows that the method works and is widely applicable in the field of mitochondrial biology. With some additional required controls and validations we would therefore find it suitable for publication in *eLife*. Below please find the requested additional experiments and textual changes:

Required changes

1\) Results, Figure 2E and text: The FACS experiment (which is actually not FACS but flow cytometry because there is no cell sorting included) requires an additional control of a strain transformed with an empty vector (EV) to show whether the Pgk-beta11 has the same intensity as the EV control or higher.

2\) Figure 2B: It is critical to compare the Pgk1 strain with the EV control in terms of fluorescence intensity to see if there is really no background. Please display these two micrographs in the GFP channel with the contrast enhanced in the same way so that the background signals are clearly visible and readily comparable. Other micrographs in this panel can be displayed with the same contrast too, if not oversaturated. Alternatively, fluorescence signal quantification can be added, so that the signals can be compared to the control experiment.

3\) To support the conclusion from your method that certain amino acyl tRNA synthetases are dually localized to the cytosol and to the mitochondrial matrix we request some validation of this data by an additional method such as biochemical fractionation or functional data for the relevance of these tRNA-synthetases for mitochondrial protein synthesis

4\) Cloning of fragments of proteins is dangerous. It was shown already in 1987 by Ed Hurt and Jeff Schatz (Nature 325, 599-503) that the subcloning of fragments of cytosolic proteins causes their artificial and misleading import into mitochondria. Thus, it is essential that the C-terminal reporter, at least of key experiments, is verified by being fused by use of expression cassettes that are integrated into the genome. This also prevents artifacts from overexpression.

5\) The claim that the current approach is superior to other split gene approaches in which both fragments of the split protein are translated in the cytosol should be further validated. At present it is based on one experiment in which a sub-optimal MTS was used for the nuclear encoded fragment (GFPβ1-10 at the C terminus of a the full GatF protein of 183aa which is claimed to have a strong MTS but this is not shown). The strongest used MTS in yeast is the 69 most N terminal amino acids of Su9. Using this MTS it has been shown that precursors are difficult to detect even in pulse chase experiments and there are no precursors accumulating in the cytosol unless the cells are under severe stress. Hence the authors should either prove that GatF MTS is an optimal signal, or else redo the control experiments with the Su9 mTS or else tone down their statement.

6\) As an extension to point 5 -- the sensitivity of the current method is not clear. If this new split system has a very low expression of GFPβ1-10 from the mitochondrial genome, it may not be sensitive enough to identify novel low expressed proteins in mitochondria. We would like to see an evaluation of how sensitive the GFPβ1-10 expressed from the mitochondrial genome is in detecting low-abundance mitochondrially targeted counterparts attached to a GFPβ11ch. Optimally this would be compared in sensitivity (and not only accuracy) to the nuclear expressed MTS-GFPβ1-10.

7\) The authors use either Pam16β11ch or Atp4β11ch as their positive mitochondrial controls. but both are membrane proteins. Please also use one soluble protein that is less abundant as a control.

8\) The authors use as a negative control, a GFPβ11ch tagged version of Pgk1, which they claim is a commonly used cytosolic marker. However, Pgk1 is annotated as having a mitochondrial pool (see for example SGD) and this may explain the background that can be seen. Maybe a purely cytosolic protein would be a better control?

10.7554/eLife.56649.sa2

Author response

> Required changes
>
> 1\) Results, Figure 2E and text: The FACS experiment (which is actually not FACS but flow cytometry because there is no cell sorting included) requires an additional control of a strain transformed with an empty vector (EV) to show whether the Pgk-beta11 has the same intensity as the EV control or higher.

We agree, this is a control missing in our experiment. We will measure the fluorescence intensity by flow cytometry of the BiG Mito-Split-GFP strain bearing the empty vector used for GFP~β11ch~ tagging and compare it to the BiG Mito-Split-GFP strain expressing Pgk1~β11ch~ and Pam16 ~β11ch~ to stay in similar conditions. It is now indicated in the revised manuscript that additional experiments are needed to verify whether the BiG Mito-Split-GFP system can be used for systematic screening.

> 2\) Figure 2B: It is critical to compare the Pgk1 strain with the EV control in terms of fluorescence intensity to see if there is really no background. Please display these two micrographs in the GFP channel with the contrast enhanced in the same way so that the background signals are clearly visible and readily comparable. Other micrographs in this panel can be displayed with the same contrast too, if not oversaturated. Alternatively, fluorescence signal quantification can be added, so that the signals can be compared to the control experiment.

As requested, we have enhanced the contrast in this figure and also added, in the source data file, new micrographs of the BiG Mito-Split-GFP strain expressing Pgk1~β11ch~, with the same "enhanced" and "not enhanced" contrast settings. In addition, we have also compared the fluorescence intensity of GFP and MitoTracker Red CMXRos signals using ImageJ software across cells of the BiG Mito-Split-GFP cells transformed with the positive controls (Pam16~β11ch~, Atp4~β11ch~), the cERS and the negative controls EV and Pgk1~β11ch~. This analysis, that shows perfect colocalization of Pam16~β11ch~, Atp4~β11ch~ and cERS~β11ch~ but not of the EV or Pgk1~β11ch~, was added as a new panel in Figure 2---figure supplement 1A which is mentioned in the revised manuscript (subsection "The BiG Mito-Split-GFP system restricts fluorescence emission to mitochondrially-localized proteins"). We will also add micrographs of the BiG Mito-Split-GFP strain expressing His3~β11ch~ that will be taken with the same enhanced contrast settings. His3~β11ch~ is another cytosolic control that we had already generated before COVID-19 confinement and that will be provided as indicated in the revised manuscript.

> 3\) To support the conclusion from your method that certain amino acyl tRNA synthetases are dually localized to the cytosol and to the mitochondrial matrix we request some validation of this data by an additional method such as biochemical fractionation or functional data for the relevance of these tRNA-synthetases for mitochondrial protein synthesis

We are conscious that the data on ~cyte~FRS2 and ~cyte~HRS are intriguing because the most recently published mitoproteomes based on purification of mitochondria followed by mass spectrometry identification (Vogtle et al., 2017) did not detect ~cyte~FRS2 and ~cyte~HRS in mitochondrial extracts. But this is not the only discrepancy that can be found between previous work and ours concerning caaRSs that can potentially relocate to mitochondria. For example, previous studies (Rinehart et al.,2005) and recent mitoproteomes (Vogtle et al., 2017) suggest that cQRS might be imported inside mitochondria. However, we unambiguously demonstrated both genetically and functionally that cQRS is not imported inside mitochondria (Frechin et al., 2009); and the micrographs of the BiG Mito-Split-GFP strain expressing cQRS~β11~ unquestionably confirmed these previous results (Figure 3). Likewise, we (Frechin et al., Genes & Dev. 2009, Frechin et al., 2014) and also others (Vogtle et al., 2017) repetitively proved the presence of cERS~β11ch~ in mitochondria, a result confirmed by micrographs the BiG Mito-Split-GFP strain expressing cERS~β11~ (Figure 2 and 3), which corresponds exactly to the verification asked by the reviewers. Moreover, the GFP signals for ~cyte~HRS~β11ch~ and ~cyte~FRS2~β11ch~ (Figure 3) seems to be even significantly stronger than for cERS~β11ch~ while being expressed at similar levels (Figure 3---figure supplement 1), suggesting that ~cyte~HRS~β11ch~ and ~cyte~FRS2~β11ch~ might even be more efficiently imported inside mitochondria than cERS~β11ch~. We therefore do not see how immunoblotting extracts of purified mitochondria would enhance the reliability of our approach especially considering that the idea behind the BiG Mito-Split-GFP is rightly to avoid biochemical fractionation and to show that alternative ways do exist to clearly identify mitochondrial proteins and echoform by simple microscopy.

The alternative request to provide data showing that the mitochondrial echoforms of ~cyte~FRS2 and ~cyte~HRS might participate to mitochondrial translation seems to us very hazardous because relocating caaRSs usually exert non-translational functions in the new compartment they reach (Yakobov et al., 2017). We are therefore inclined to believe that the mitochondrial echoforms of ~cyte~FRS2 and ~cyte~HRS will very probably not participate to mitochondrial translation. Furthermore, as these forms are essential for cytosolic translation, generating mutants of ~cyte~FRS2 and ~cyte~HRS that have conserved their function in cytosolic translation while being impaired for their mitochondrial role, whatever this role might be, is far from being an obvious, fast and effortless task. It will inevitably require that we first identify the cryptic MTS of both ~cyte~FRS2 and ~cyte~HRS and second that their removal doesn't impair the cytosolic activity of both enzymes. If this is the case, then we might be able to decipher the mitochondrial roles of ~cyte~FRS2 and ~cyte~HRS. However, I hope that the reviewers can understand that this will not be a swift verification but will rather constitute, by itself, a whole new research project.

However, if having another validation of the mitochondrial import of ~cyte~FRS2 and ~cyte~HRS appears to be crucial to the reviewers, we will check by immunoblotting of pure mitochondrial extracts the presence of these echoforms and add it to the BioRxiv file that will be linked to our manuscript.

> 4\) Cloning of fragments of proteins is dangerous. It was shown already in 1987 by Ed Hurt and Jeff Schatz (Nature 325, 599-503) that the subcloning of fragments of cytosolic proteins causes their artificial and misleading import into mitochondria. Thus, it is essential that the C-terminal reporter, at least of key experiments, is verified by being fused by use of expression cassettes that are integrated into the genome. This also prevents artifacts from overexpression.

We assume that the reviewers refer to the experiments shown on Figure 4A and 4C in which we show the micrographs we obtained by fusing to GFP~β11ch~, various fragments of the N-terminal GTS-like domain of cERS. We do agree with the reviewer that mislocalization can be triggered with N-terminal protein fragments and lead to false positive identification of organellar-targeted proteins, and that verifying the localization of the corresponding C-terminal part, is a needed control. We believe that the data shown in Figure 4A (now Figure 4B of the revised manuscript) provide these verifications. Indeed, they show that the 200 N-terminal residues of cERS (cERS~β11ch~-N3) trigger mitochondrial targeting of GFP~β11ch~ while, as expected, removing them from cERS~β11ch~ (cERS~β11ch~-∆N2) prevent its mitochondrial import. Likewise, the 30 fist N-terminal residues of cERS (cERS~β11ch~-N1) trigger mitochondrial targeting of GFP~β11ch~ while removing them from cERS~β11ch~ cERS~β11ch~-∆N1) prevent its mitochondrial import. As was done by Hurt and Schatz in their 1987 Nature paper, we generated the N-terminal fragments of cERS according to the structure that was published by Simader and coworkers in their 2006 NAR paper, making sure that the truncations were exclusively done in loops and not in the middle of an a-helix or a β-strand.

Moreover, the DHFR fragment that was identified by Hurts and Schatz, in their 1987 Nature paper and which is acting as an artificial MTS, contained an a-helix which resembles a mitochondrial pre-sequence: 3 positively-charged residues (interspaced by 3 aa residues), 1 Glu and 3 Thr residues. To the contrary, the 30 first aa residues of cERS contain one a-helix of 10 residues that only contains 1 Arg but also 1 Glu (see Figure 4B of the revised manuscript) which, by far, does not correspond to a *bona fide* mitochondrial pre-sequence that could trigger artificial mislocalization of a fused peptide, unless it is really a new type of MTS whose mechanistic traits have yet to be deciphered.

If we well understood, the second concern of the reviewers were artificial localization originating from overexpression. We would like to emphasize that caaRSs are naturally abundant proteins in yeast cells (30.000-40.000 exemplar / cell on average with around 10 hours half-life -- SGD) and the cERS fragments and truncated variants were expressed under the dependence of a GPD promoter which has a strength similar to that of the aaRSs endogenous promoters and comparable to the ADH promoter that was used by Hurt and Schatz in their 1987 Nature paper. Interestingly, in their paper, Hurts and Schatz unambiguously show that despite comparable overexpression of various parts of the 85 N-terminal aa residues of DHFR, only the one containing the cryptic MTS (see previous paragraph) triggers mitochondrial import in vivo. This shows that overexpression is less prone to trigger mitochondrial mistargeting than the artificial presence of a mitochondrial pre-sequence.

It is true that we did not chromosomally integrate the GFP~β11ch~-tagged N-terminal fragments of cERS~β11~ or the N-terminally truncated cERS~β11ch~ variants but we expressed them from a low-copy plasmid that mimics the number of chromosomal gene copies. In addition, the micrographs of the BiG Mito-Split-GFP strain in which we chromosomally integrated cERS~β11ch~ expressed under the dependence of its natural promoter are comparable to the micrographs obtained with the BiG Mito-Split-GFP strain transformed with a single-copy plasmid expressing cERS~β11ch~ under the dependence of the GPD promoter. Therefore, we don't think that the mitochondrial localizations we observe in Figure 4A (now Figure 4B of the revised manuscript) are artificially caused by the truncations we made or overexpression.

However, to overcome problems originating from the nomenclature we used in Figure 4A (now Figure 4B of the revised manuscript), we changed it and to simplify this figure we have added a new figure (Figure 4A of the revised manuscript) showing the drawings of the N-terminal fragments and truncated variants of cERS. We also added the aa sequence of thee a-helices on the schematized secondary structure of the N-terminal par of cERS.

Concerning the N-terminal part of cCRS, as we mentioned in the revised manuscript, we were unable to get *E. coli* transformants bearing a plasmid with the full-length cCRS gene, despite repeated attempts and using different cloning procedures (Gateway-, Gibson-, regular restriction enzyme-mediated cloning procedures). However, while we were doing our experiments with the N-terminal domain of cCRS, the 2019 paper by Nishimura and coworkers (J. Biol. Chem.294 13781-13788) proved that the mitochondrial and cytosolic echoforms are generated through a combination of alternative transcription and translation initiation. Given that the N-terminal sequence of cCRS we used corresponds to that present in the mitochondrial echoform characterized by Nishimura and coworkers, we did not further pursue on trying to get the C-terminal part of cCRS cloned because our BiG Mito-Split-GFP data were in agreement with theirs.

> 5\) The claim that the current approach is superior to other split gene approaches in which both fragments of the split protein are translated in the cytosol should be further validated. At present it is based on one experiment in which a sub-optimal MTS was used for the nuclear encoded fragment (GFPβ1-10 at the C terminus of a the full GatF protein of 183aa which is claimed to have a strong MTS but this is not shown). The strongest used MTS in yeast is the 69 most N terminal amino acids of Su9. Using this MTS it has been shown that precursors are difficult to detect even in pulse chase experiments and there are no precursors accumulating in the cytosol unless the cells are under severe stress. Hence the authors should either prove that GatF MTS is an optimal signal, or else redo the control experiments with the Su9 mTS or else tone down their statement.

We did not there *per se* claim that our approach is superior but rather that it is significantly more reliable in avoiding false positives than when both fragments are translated in the same compartment. However, the reviewers are right, we did not present in the manuscript, data to support that GatF's MTS is an optimal MTS. But, taking into account all currently existing data on GatF in the literature, I do not see how the reviewers came to the conclusion that GatF's MTS is sub-optimal, either.

We generated the MTS-based Split-GFP fragments to be able to evaluate the possibility that the cytosolically-translated MTS-GFP~β1-10~ could bind Protein X-GFP~β11~ before its import and thus mislabel mitochondria by assembling at the surface of mitochondria rather than inside. This is also why we used Pgk1~β11ch~ as our cytosolic control (see reviewers' comment \#8) because a fair proportion of this cytosolic protein was demonstrated to be located at the external surface of mitochondria. We were aware that the strength of the MTS we would fuse to GFP~β1-10~ had to be taken into consideration because its strength might impact the time during which the MTS-GFP~β1-10~ resides at the surface of mitochondria. We assumed that the weaker the MTS would be, the longer the MTS-GFP~β1-10~ would accumulate near the mitochondrial surface rather than being imported inside the organelle. This is why we generated two MTS-GFP~β1-10~ and compared their efficiency in generating a mitochondria-specific GFP labeling that could be detected by epifluorescence microscopy, when co-expressed with the dual-localized cERS~β11ch~. The two MTS we compared were the entire GatF protein that we had both functionally and structurally characterized, and the MTS of the mitochondrial malate dehydrogenase (Mdh1) (see [Author response image 1](#sa2fig1){ref-type="fig"}).

![Efficiency of mitochondria-specific GFP labeling induced by MTS-MDHβ1-10 compared to that of GatFβ1-10.\
*Saccharomyces cerevisiae* gus1∆ strain complemented with the pRS414 plasmid expressing cERSβ11ch was transformed with a pRSX expressing either MTS-MDHβ1-10 (A and C) or GatFβ1-10 (B and D) and grown either on SC-Glu (A and B) or SC-Gly (C and D). Epifluorescence micrographs were taken with an AXIO Observer d1 (Carl Zeiss) epifluorescence microscope using a 100 × plan apochromatic objective (Carl Zeiss) and processed with the Image J software. Arrowheads: mitochondria.](elife-56649-resp-fig1){#sa2fig1}

As can be seen in B and D, GatF~β1-10~ allows efficient and specific labeling of mitochondria with almost no cytosolic background both in SC-Glucose and SC-Glycerol media. Conversely, in SC-Glucose, MTS-MDH~β1-10~ (A) does not yield a mitochondrial GFP signal that can be distinguished from the residual cytosolic one. In SC-Glycerol, one can start to distinguish mitochondria when MTS-MDH~β1-10~ is used (C), but the mitochondrial GFP signal is weak and there is still a significant cytosolic GFP signal. Because GatF~β1-10~ generates a strong mitochondrial GFP signal with almost no contaminated cytosolic GFP emission, compared to MTS-MDH~β1-10~, we concluded that GatF can be considered as a strong MTS. We did not evaluate GatF's import strength compared to that of the MTS of the heterologous *Neurospora crassa* Atp9 subunit, but we hope that our comparative study using endogenous *S. cerevisiae* MTSs will convince the reviewers that, *a minima*, GatF can be considered as an efficient MTS; and thus supports our conclusion that the BiG Mito-Split-GFP constitutes indeed a significantly more reliable approach for visualizing mitochondrial echoforms of dual-localized proteins. We nevertheless completely modified this part of the manuscript which is now: "We next evaluated whether the BiG Mito-Split-GFP approach represents a significant technical advance compared to the existing MTS-based Split-GFP methods that are currently used. To this end, we constructed cells (with a wild type mitochondrial genome) that co-express in the cytosol the mitochondrial protein GatF (with its own MTS) fused at its C-terminus with GFP~β1-10~ (mtGatF~β1-10~) and either cERS~β11ch~ (dual localized, positive control) or Pgk1~β11ch~ (cytosolic, negative control) (Figure 2F, left panel). As expected, a strong and specific mitochondrial fluorescent signal was obtained with cERS~β11ch~ (Figure 2F, right panel)."

> 6\) As an extension to point 5 -- the sensitivity of the current method is not clear. If this new split system has a very low expression of GFPβ1-10 from the mitochondrial genome, it may not be sensitive enough to identify novel low expressed proteins in mitochondria. We would like to see an evaluation of how sensitive the GFPβ1-10 expressed from the mitochondrial genome is in detecting low-abundance mitochondrially targeted counterparts attached to a GFPβ11ch. Optimally this would be compared in sensitivity (and not only accuracy) to the nuclear expressed MTS-GFPβ1-10.

We agree that knowing how sensitive the BiG Mito-Split-GFP method is, is an important issue, which we did not sufficiently address. The yeast proteins we've tested are indeed far from being weakly expressed: Pam16 (3000 copies), Atp4 (30.000-40;000 copies), caaRSs (13.000-70.000 copies). By looking at most recent proteomics data reporting on the copy number of proteins found inside mitochondria (Vogtle et al., 2017), we noticed that mitochondrial GatF protein (*GTF1*) is a low-expressed protein (40-80 copies in cells grown in YPGal or YPGly). Since we already generated a plasmid expressing GatF~β11ch~ under the dependence of a GPD promoter, we propose to swap this promoter by the *GTF1* endogenous one and to compare the intensity the BiG Mito-Split-GFP strain expressing GatF~β11ch~ under the dependence of its own promoter to that of cERS~β11ch~ for example. This additional experiment to be reported later and its importance, is mentioned in the revised manuscript.

> 7\) The authors use either Pam16β11ch or Atp4β11ch as their positive mitochondrial controls. but both are membrane proteins. Please also use one soluble protein that is less abundant as a control.

We do not fully agree with the reviewers on this point, at least as far as Pam16 is concerned. This is not a *bona fide* inner membrane protein. It has been shown it is translocated into the mitochondrial matrix where it associates to the mtHsp70 before reaching the TIM complex where it interacts with Tim44 (a true integral membrane protein). This seem to be a common feature of matrix proteins because when we looked at the most recent data that report localization of mitochondrial proteins (Vogtle et al., 2017, supplementary file 4), the degree of precision that authors can reach for the sub-mitochondrial does not allow the separation between the matrix and the inner mitochondrial membrane. In this report, authors separate submitochondrial compartments into: OM (outer membrane), IMS/IM (intermembrane space / Inner Membrane) and matrix/IM (matrix/Inner Membrane). We are wondering if one can find a matrix-restricted protein which is not a peripheral mitochondrial inner membrane protein because it, at least, transiently can interact with proteins or protein complexes that are embedded in the inner membrane.

We, therefore, do not think that another so-called matrix protein -- probably annotated as a matrix/inner membrane protein -- would be a better positive control than Pam16, unless the reviewers have a particular matrix-restricted protein in mind that we haven't come across in our analysis of the literature.

> 8\) The authors use as a negative control, a GFPβ11ch tagged version of Pgk1, which they claim is a commonly used cytosolic marker. However, Pgk1 is annotated as having a mitochondrial pool (see for example SGD) and this may explain the background that can be seen. Maybe a purely cytosolic protein would be a better control?

If we may, our claim that Pgk1 is a cytosolic marker commonly used rests on the large number of studies in which Pgk1 has indeed been used as a cytosolic marker on WB. As we mentioned in our initial manuscript, Pgk1 localizes in part at the surface of mitochondria but once purified mitochondria are treated with proteinase K, this pool totally disappears, showing that Pgk1 is not internalized inside mitochondria (Cobine et al., 2004; Levchenko et al., 2016; Kritsiligkou et al., 2017). We changed this paragraph in the revised manuscript. Moreover, as already mentioned in our answer to the 2^nd^ major comment, we will provide micrographs of the BiG Mito-Split-GFP strain expressing His3~β11ch~ as another negative control in the BioRxiv addendum that will be linked to our revised manuscript. This is now mentioned in of the revised manuscript.
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